• BARR PHARMACEUTICALS INC Income Statement

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2007 FY2006 FY2005 FY2004 FY2003
    Net Sales/Revenues 2.50 B 1.31 B 1.05 B 1.31 B 902.86 M
    Cost of Goods Sold (Excluding Depreciation) 873.28 M 290.14 M 263.26 M 600.69 M 401.39 M
    Depreciation, Depletion and Amortization 297.82 M 61.98 M 40.82 M 32.06 M 22.71 M
    Gross Income 1.33 B 962.35 M 743.32 M 676.34 M 478.76 M
    Selling, General & Admin Expenses 1.01 B 451.63 M 364.09 M 318.56 M 248.24 M
    Other Operating Expense 0.00 0.00 0.00 0.00 0.00
    Operating Expenses - Total 207.83 M 99.21 M 151.89 M 117.97 M 66.11 M
    Operating Income 317.25 M 510.72 M 379.23 M 357.78 M 230.53 M
    Extraordinary Credit - Pretax 0.00 0.00 4.60 M 0.00 31.40 M
    Extraordinary Charge - Pretax 4.60 M 23.30 M 63.20 M 164.93 M 4.16 M
    Non-operating Interest Income 33.36 M 18.85 M 11.45 M 5.77 M 6.34 M
    Reserves Inc (Dec) 0.00 0.00 0.00 0.00 0.00
    Pretax Equity in Earnings 0.00 0.00
    Other Income/Expenses - Net 19.54 M 11.94 M 59,000.00 -187,000.00 86,000.00
    Earnings Before Interest & Taxes (EBIT) 365.54 M 518.21 M 332.14 M 198.43 M 264.19 M
    Interest Expenses On Debt 158.88 M 489,000.00 1.46 M 2.64 M 3.24 M
    Interest Capitalized 0.00 0.00 0.00 0.00 1.76 M
    Pretax Income 206.66 M 517.72 M 330.67 M 195.79 M 262.72 M
    Income Taxes 64.55 M 186.47 M 114.89 M 71.34 M 95.15 M
    Current Domestic Income Tax 118.78 M 151.73 M 107.84 M 119.57 M 88.53 M
    Current Foreign Income Tax 17.20 M 0.00 0.00 0.00 0.00
    Deferred Domestic Income Tax -8.69 M 34.74 M 7.05 M -48.24 M 6.62 M
    Deferred Foreign Income Tax -62.75 M 0.00 0.00 0.00 0.00
    Income Tax Credits
    Minority Interest 1.16 M -1.26 M 0.00 0.00 0.00
    Equity in Earnings 1.18 M 5.22 M -796,000.00 -1.35 M 0.00
    After Tax Income Expense 0.00 0.00 0.00 0.00 0.00
    Discontinued Operations -13.78 M 0.00 0.00 0.00 0.00
    Net Income Before Extra Items/Preferred Div 128.35 M 336.48 M 214.99 M 123.10 M 167.57 M
    Extra Items & Gain (Loss) Sale of Assets 0.00 0.00 0.00 0.00 0.00
    Net Income Before Preferred Dividends 128.35 M 336.48 M 214.99 M 123.10 M 167.57 M
    Preferred Dividend Requirements 0.00 0.00 0.00 0.00 0.00
    Net Income Available to Common 142.12 M 336.48 M 214.99 M 123.10 M 167.57 M